Exclusive Papers of the Editorial Board Members (EBMs) of Hemato

Dear Colleagues,

This Special Issue of Hemato is dedicated to recent advances in hematology, hematopathology, cellular biology, immunology, and molecular biology research areas and comprises a diverse selection of exclusive papers of the Editorial Board Members (EBMs) of Hemato. It focuses on highlighting recent interesting investigations conducted in the laboratories or clinics of our journal’s EBMs and represents our journal as an attractive open-access publishing platform for hematology-related research data.

Prof. Dr. Antonino Carbone
Dr. Laurent Garderet
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the collection website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Hemato is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.